Home
Conditions
Hematologic Diseases

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,392 public trials 2,850 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Recruiting

A Registry for the Food Allergy Community

NCT04653324

Conditions: Anaphylaxis, Digestive System Diseases, Eosinophilia, +18 more
Locations: Food Allergy Research & Education McLean, Virginia, United States

View Trial Details

Recruiting

Off-the-shelf CD123 CAR-NK for R/R AML

NCT06201247

Conditions: Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse, Hematologic Diseases, +6 more
Locations: Peking University People's Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

CD-19 CAR-T Cell for Pediatric ALL or Lymphoma

NCT06866873

Conditions: Acute Lymphoblastic Leukemia, Pediatric, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
Locations: Hong Kong Children's Hospital Hong Kong

View Trial Details

Recruiting

Study of Oral PCLX-001 in R/R Acute Myeloid Leukemia

NCT06613217

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +5 more
Locations: MD Anderson Cancer Centre Houston, Texas, United States

View Trial Details

Recruiting

A Clinical Trial of BP1002 in Patients With Refractory/Relapsed Acute Myeloid Leukemia (AML)

NCT05190471

Conditions: Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse, Hematologic Diseases, +6 more
Locations: Scripps Green Hospital La Jolla, California, United States

UCLA Medical Center Los Angeles, California, United States

Weill Cornell Medical College - NewYork-Presbyterian Hospital New York, United States

MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Assessing Different FVIII Doses and Frequencies in Immune Tolerance Induction (ITI) with ADVATE Among Hemophilia a Boys with Inhibitor (INITIATE Study)

NCT06864975

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations: Beijing Children's hospitial Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML

NCT02781883

Conditions: Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: UCLA Medical Center Los Angeles, California, United States

Georgia Cancer Center at Augusta University Augusta, Georgia, United States

University of Kansas Cancer Center Fairway, Kansas, United States

New Jersey Hematology Oncology Associates Brick, New Jersey, United States

View Trial Details

Recruiting

Tasquinimod in Patients with Myelofibrosis Refractory to or Intolerant for JAK2 Inhibition

NCT06605586

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations: DE-Aachen-UKAACHEN Aachen, Germany

NL-Amsterdam-AmsterdamUMC Amsterdam, Netherlands

NL-Groningen-UMCG Groningen, Netherlands

NL-Nijmegen-RADBOUDUMC Nijmegen, Netherlands

View Trial Details

Recruiting

Thiotepa, Cyclophosphamide, Clarithromycin and Cytarabine

NCT06060782

Conditions: Acute Lymphoblastic Leukemia, Adult, Burkitt Lymphoma, DNA Virus Infections, +20 more
Locations: The Fifth Affiliated Hospital of Sun Yat-sen University Zhuhai, Guangdong, China

View Trial Details

Recruiting

Safely Delivered Targeted High-dose Irradiation Followed by Adoptive Immunotherapy with Regulatory and Conventional T Cells to Increase Potency of Hematopoietic Stem Cell Transplantation in High-risk Acute Leukemia

NCT06845592

Conditions: Acute Lymphoblastic Leukemia ALL, Acute Myeloid Leukaemia (AML), Disease Attributes, +18 more
Locations: Università degli Studi di Perugia Perugia, PG, Italy

View Trial Details

Hematologic Diseases

Hematologic Diseases trial results

Related conditions